NVRO Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Nevro Corp. Stock Analysis NVRO
United States Health Care Micro Cap Nevro Corp. engages in the development of medical devices. The company is headquartered in Redwood City, California and currently employs 1,099 full-time employees. The company went IPO on 2014-11-06. The firm is focused on delivering solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. Its comprehensive HFX spinal cord stimulation 3 (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. The company has developed and commercialized its HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain, with the Senza HFX iQ platform. Its HFX solution delivers a range of waveforms, including its paresthesia-free 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain. Its products include Senza II SCS System, Senza Omnia SCS System, Senza Omnia upgrade, Omnia Powered by HFX Connect, Senza HFX iQ System, and Surpass Surgical Lead.
Read More NVRO Chart
Nevro Corp vs S&P 500 Comparative Returns
Analysis of NVRO stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Nevro Corp (NVRO) 56.99%
- S&P 500 -4.27%
Nevro Corp Outperformed S&P 500 by 61.26%
1Y Performance
- Nevro Corp (NVRO) -54.12%
- S&P 500 8.86%
Nevro Corp Underperformed S&P 500 by 62.98%
3Y Performance
- Nevro Corp (NVRO) -92.36%
- S&P 500 37.21%
Nevro Corp Underperformed S&P 500 by 129.57%
5Y Performance
- Nevro Corp (NVRO) -93.78%
- S&P 500 92.3%
Nevro Corp Underperformed S&P 500 by 186.08%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$5.84Volume
753.60KP/E Ratio (TTM)
-52 Week Range
Market Cap
222.17MAvg. Volume
1.19MDividend Yield
-Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenue per Share (TTM) | 10.46 | 10.84 | 11.45 | 11.69 | - |
EBIT per Share (TTM) | -1.82 | -2.55 | -2.78 | -2.73 | - |
Earnings per Share (EPS) (TTM) | - | - | 0.08 | - | - |
EPS Forward | -2.47 | -3.78 | 0.08 | -2.56 | - |
Super Investors
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Community-Curated Collections ( With NVRO )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
